跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ON-203
首页
药物
ON-203
ON-203
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS AND SYSTEMS FOR ADAPTING PATHLENGTH AND/OR WAVELENGTH OF A UV-ABSORBANCE CELL IN A CHROMATOGRAPHY SYSTEM
EP 3586123 A2
申请人: GE HEALTHCARE BIO SCIENCES AB
优先权: 2017
CN
EP
US
WO
4 件公开
METHOD OF DRY GRANULATION USING A ROLLER COMPACTOR
EP 3914383 C0
申请人: NOVO NORDISK AS
优先权: 2019
CN
EP
US
WO
4 件公开
RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN
EP 4331624 A1
申请人: INSTITUTO NAC DE INVESTIGACIONES NUCLEARES
优先权: 2021
CN
EP
US
WO
4 件公开
Traditional Chinese medicine physiotherapy sickbed and using method thereof
CN 111544224 A
申请人: BEIJING LUOBIDA TECH CO LTD
优先权: 2018
CN
2 件公开
Double-reporter-gene recombinant adenovirus vector, construction method and application thereof
CN 103160539 A
申请人: GAO FABAO
优先权: 2012
CN
Therapeutic agent for corneal epithelial disorder
US 9562231 B2
申请人: SENJU PHARMA CO
优先权: 2013
US
Method and Device for Detecting Analytes
US 2014234219 A1
申请人: PANASONIC CORP
优先权: 2014
US
Method for producing recombinational anti-tumor 19 peptide by applying escherichia coli as biological reactor
CN 104593402 A
申请人: UNIV JILIN AGRICULTURAL
优先权: 2015
CN
METHOD FOR EXPANDING STEMNESS AND DIFFERENTIATION POTENTIAL OF PLURIPOTENT CELLS
EP 3406712 A1
申请人: FUNDACION CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III
优先权: 2017
EP
Method for adjusting prostate cancer tumor angiogenesis by utilizing miR-203/SNAI2 axis
CN 110117651 A
申请人: TIANJIN COME BIOTECHNOLOGY CO LTD
优先权: 2018
CN
第 1 / 2 页
上一页
下一页
药物
反馈